Plasma Fractionation Market to Reach USD 38.65 Bn by 2026, Kedrion Biopharma’s FDA Approval to Create Attractive Growth Opportunities: Fortune Business Insights

NEXT STORY
Angion Presents Data on the Impact and Burden of Delayed Graft Function at the American Society of Nephrology Kidney Week 2019
PREV STORY
Ziopharm Oncology Presentation at the Jefferies 2019 London Healthcare Conference to be Webcast
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Precision Therapeutics Investee, Helomics Corporation, Launches Precision Oncology Insights Platform

MINNEAPOLIS, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or ...

author_avatar
NASDAQ Market News

Leap Therapeutics to Present at 2018 Barclays Global Healthcare Conference

CAMBRIDGE, Mass., March 07, 2018 (GLOBE NEWSWIRE) -- Leap Therapeutics, Inc. (NASDAQ:LPTX), a biotechnology ...

author_avatar
NASDAQ Market News

Phase 2 Ready Oncology Drug Receives FDA Orphan Drug Designation

SAN DIEGO, Sept. 17, 2018 (GLOBE NEWSWIRE) -- Cytori Therapeutics (NASDAQ: CYTX) (“Cytori” or ...

author_avatar
NASDAQ Market News